118 related articles for article (PubMed ID: 25481761)
1. Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones.
Iwata S; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
J Infect Chemother; 2015 Apr; 21(4):308-11. PubMed ID: 25481761
[TBL] [Abstract][Full Text] [Related]
2. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
Liu Y; Xu H; Xu Z; Kudinha T; Fan X; Xiao M; Kong F; Sun H; Xu Y
Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
[TBL] [Abstract][Full Text] [Related]
3. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
[TBL] [Abstract][Full Text] [Related]
4. Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011.
Flamm RK; Sader HS; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2012 Oct; 74(2):198-200. PubMed ID: 22819241
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
6. High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China.
Liu Y; Zhao C; Zhang F; Chen H; Chen M; Wang H
Microb Drug Resist; 2012 Aug; 18(4):417-26. PubMed ID: 22394083
[TBL] [Abstract][Full Text] [Related]
7. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
8. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
[TBL] [Abstract][Full Text] [Related]
10. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
Sahm DF; Brown NP; Thornsberry C; Jones ME
Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of macrolides against gram-positive aerobes, Haemophilus influenzae, Moraxella catarrhalis and Bacteroides fragilis in Taiwan.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):230-5. PubMed ID: 10367484
[TBL] [Abstract][Full Text] [Related]
16. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Jones RN; Fritsche TR; Sader HS; Stilwell MG
Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
[TBL] [Abstract][Full Text] [Related]
17. Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated
Yamada K; Saito R; Muto S; Kashiwa M; Tamamori Y; Fujisaki S
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760904
[No Abstract] [Full Text] [Related]
18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility and impact of macrolide antibiotics on Moraxella catarrhalis in the upper and lower airways of children with chronic endobronchial suppuration.
Hare KM; Seib KL; Chang AB; Harris TM; Spargo JC; Smith-Vaughan HC
J Med Microbiol; 2019 Aug; 68(8):1140-1147. PubMed ID: 31274402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
